You may not realize the impact that mold has on your health. That is, until you suffer from the affects it has on your air quality. If you are experiencing allergies, it may be because of the fungus that is present in your home.am allergic to peanuts. The allergy is not as dangerous as the kiss of death reaction some people have, but I can still feel short of breath if I accidentally consume the nuts. After watching this movie, I decided to see if the forking tactic could actually work on real people. I took a fork, scraped my skin and rubbed the area with a peanut. The result was the effect many common allergies and symptoms have on the body, a rash. I had proven the test effective and I went to bed happy with my ingenuity.There is lots of way in chronic sinusitis treatment, but until now there is no 100% guarantee treatment for it. The goal in treating sinusitis is to eliminate or reduces the inflammation and congestion of sinus to improve the quality of life. If you went to visit a doctor for chronic sinusitis treatment, he will only recommend 2 ways to cure it, which includes using antibiotics to relieve your sinus (either eatable or something to spray on sinus). Using medicine might incurred certain side effects like sneezing, headache and even nose bleeding, which I don’t recommend you to try it.

More often than not, people think an allergy to food means an immediate negative response. However, there are many hidden food allergies that present themselves in subtle symptoms that are overlooked, such as a headache or sinus congestion. Wheat and dairy are known to be fairly common hidden food allergens, but there are others including soy, tomatoes and more. By removing possible allergens and reintroducing them one at a time, you can find out if your baby’s eczema is caused by a food allergy or perhaps another external factor.Detergents, cigarette smoke, house dust and more can also be an underlying cause for baby eczema. Allergy testing can also help determine what might be causing the symptoms, but keeping a log of what baby is exposed to might also help. Using hypo-allergenic detergents and a mild cleanser can help eliminate issues with these items.

Dry, itchy skin isn’t usually associated with food; and yet this common skin problem can be caused by having a hidden food allergy to a certain food, like wheat or even dairy. By finding out all of the different foods that can cause eczema and strategically eliminating and reintroducing them, it is possible to cure eczema simply by staying away from a particular food.As with eczema, asthma can also be caused by eating a food that your system is particularly sensitive to. It can be difficult sometimes to find out exactly which food is causing the problem; but allergy testing or food elimination diets can help you decipher which foods you should probably stay away from. It is possible to even go off of allergy medications and/or stop using an inhaler simply by removing the food that is causing the asthma in the first place.A stuffy nose is not normally connected to having a problem with a food like dairy. External allergens are usually blamed for causing this problem, but nonetheless, sinusitis can be caused by having a hidden food allergy; if that certain food that bothers your system is removed, the stuffy nose will clear up and quickly within a few days or weeks.

Visit for more useful information on symptoms of allergies and alpha-1 antitrypsin deficiency also attention deficit hyperactivity disorder .

You might also enjoy:

• What are some gluten/wheat free options for breakfast out?
• Would mold allergies be helped by moving to Utah or Arizona?
• Gluten Free foods are the fastest growing food category since 2004, see the growth forecasts up to 2012!
• millet “rice” pudding
• Doctor’s Talk: Asthma, allergy, its treatment and cure Part 1

You might also enjoy:

• Treating Allergy
• Pie Crust
• Food Allergy In Dogs: Their Next Bite Could Be Worse Than Their Bark!
• Mold Removal in Westchester New York NY
• What can a person do when your allergies are mold allergies?

Similar Allergy Articles

• Mold Allergy Symptoms and Treatments
• Treating Allergy
• Peanut Allergy – What You Need To Know
• Gluten Free Diets : Household Food With Gluten
• Allergies Symptoms and Natural Foods That Fight Allergies

If you are an allergy sufferer, spring can be a miserable time of wheezing, sneezing, coughing, and constant discomfort, unless you have the proper allergy treatment . The type of allergy treatment that is right for you depends on a number of factors that your doctor should discuss with you, but many of them take several weeks, to months to work, so you shouldn’t delay. You’ve got to start treating your allergic reactions today.

The most common allergy treatment is the antihistamine. Recently, claritin which is one of the most common antihistamines and used to be available only by prescription, has become available over the counter to treat allergies.

For many people, this proves to be such an effective allergy treatment that it proves to be all that they need to treat their conditions, but for many more, this is not the case. There are a variety of nasal allergy treatments which can relieve swelling and discomfort in the nose and sinuses, but many of these have side effects. If you suffer from bad allergic reactions, you should consider a more complete allergy treatment.

What I recommend is to take several steps, instead of looking for the cure-all allergy treatment. The first thing to do is to make sure that your house is clean. Clean out the refrigerator and check it for mold. Same goes for the bathroom, and any other room which may harbor dirt, dust, or fungus. Remember that the most effective allergy treatment is to prevent the inhalation of allergens in the first place, and that means dusting, washing, vacuuming and sweeping every single day of the week.

Of course, this isn’t the whole allergy treatment. In addition to cleaning up, you should get a nice HEPA air filter to clean up the air in your rooms, particularly the one you sleep in. This will remove all of the dirt and allergens from the air. Your allergy treatment will probably also include the use of an antihistamine, as well as a decongestant. Finally, you might have to get more severe medication as an allergy treatment. Shots can do wonders to minimize allergic reactions.

Similar Allergy Articles

• Allergy Cure and Treatment (News Channel 5 Segment)
• www.Pain-In-My-Back.com Dr Vance Interview #1
• Allergy Treatment – Take Several Steps

You might also enjoy:

• Kahlua Cake 1/18/10
• What is the best known treatment available for Chronic Cholinergic Hives?
• Gluten Free Biscuits from Ann’s Kitchen
• Chapattis, Roti Making machine
• About Glutafin

Similar Allergy Articles

• Allergy Treatment Begins At Home – Living A Healthy Lifestyle.
• www.Pain-In-My-Back.com Dr Vance Interview #1
• Allergy Treatment – Take Several Steps

You might also enjoy:

• Dining Out with Food Allergy
• 207: Pies on Parade
• UV Sterilization is an Environmentally Friendly Technology
• Milk-The Deadly Poison
• Allergies Symptoms And Treatment.

Allergic rhinitis , also called nasal allergies, pollinosis, or hay fever occurs when an allergen comes into contact with the nasal membranes.  Ragweed allergies or hay fever usually flares up during the change of season from summer to fall, usually in mid-August and lasts until the first frost Each individual has their own tendency to develop allergies as it is passed down through one’s genes. An allergy is an overreaction of the immune system to a substance that is normally harmless to most people. But sometimes, the body’s immune system treats the allergen as an invader and tries to protect the body by releasing various chemicals. This hypersensitivity of our immune system results in allergy symptoms that could be quite uncomfortable. The symptoms may range from sneezing, coughing, runny nose, itchy eyes, nose and throat, to headache, smell impairment, and wheezing.

Mold allergies occur when an allergic individual develops a hypersensitivity reaction to mold spores.  Mold spores are microscopic particles that get released from molds and become airborne.  Molds are found in damp areas, both in indoor or outdoor areas.  Mold spores can be released from the soil when disturbed by mowing the grass, raking the leaves or even after a gentle rain shower. Mold problems can occur indoors when there are water or humidity problems within a building.  Mold spores can become dispersed indoors even with the slightest disturbance. The best way to avoid outdoor mold exposure is to stay indoors when activities that disturb the soil occurs such as mowing, raking or after a slight shower.  Indoor mold problems can be mitigated by controlling water or humidity problems, and using fungicidal agents such as bleach.  These environmental control measures are important to prevent exposure and result in decreased allergy symptoms.  It would be best to be evaluated by an allergist to get a better understanding of one’s allergies, and get advice on the appropriate environmental control measures.

Similar Allergy Articles

• What are Allergy Shots For?
• Research Study on Investigational Ragweed Allergy Treatment
• Best Seasonal Allergy Treatments that you can Explore
• Allergies Symptoms and Natural Foods That Fight Allergies
• Mold Allergy- Treatment of Its Causes

Report Description

The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications. The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market.

Biomaterials products had a market size of $25.5 billion in 2008, and the biomaterial device market size was $115.4 billion in the same year, and is expected to reach $252.7 billion in 2014. This massive revenue potential highlights the immense opportunity in the market. In the next five years, the biomaterials market is expected to grow at a CAGR of 15%.

Improved patient benefits form the most important factor stimulating market growth for biomaterials. The other market drivers are increase in aging population, rising awareness, shorter product approval time, and larger application area. However, the lack of tissue availability and proper reimbursement facilities are restraining the growth of the biomaterials market.

Improvement in fabrication technology and new product development at competitive prices will be the key to future market growth. The U.S. and Europe hold a major share of the global biomaterials market; while emerging economies such as China, India, Japan, Brazil, Russia, and Romania represent a high growth rate.

REPORT DESCRIPTION

This report uses the term biomaterials to refer to the materials used in the human body. The report segments the global biomaterial market as follows:

• Biomaterials product market Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others
• Biomaterials ingredient market Metals, polymers, ceramics, composites
• Biomaterials application market General, surgical appliances and supplies, surgical and medical instruments, dental products, electro-medical equipment, in-vitro diagnostic products, and other applications

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 50 company profiles for each of its sub-segments.

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
• We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for the following sectors:

Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Table of Content

1. CHAPTER ONE: INTRODUCTION
2. Chapter two: Summary
3. Chapter three: Market overview
3.1. Driving factor analysis of Global biomaterial market
3.2. Defining the global biomaterial market
3.3. DEFINING The biomaterial DEVICE MARKET
3.4. Market drivers of biomaterial market
3.4.1. new and improved technologies
3.4.2. Advances in understanding of elementary biocompatibility science
3.4.3. Large application area
3.4.4. Introduction of bio-absorbable biomaterial products
3.4.5. Rising awareness
3.4.6. Development of synthetic biomaterials for medical applications
3.4.7. increase in aging population
3.4.8. Medical insurance coverage
3.4.9. Recent development in biomaterial research
3.4.10. Heightened interest in personal healthcare
3.5. Market inhibitors
3.5.1. Lack of tissue availability
3.5.2. Lack of proper reimbursement facilities
3.6. Opportunities
3.6.1. Streamlining issues in partnerships
3.6.2. Market participation by smaller companies
3.6.3. Growing need for integrated and combined materials
3.6.4. Development of new intelligent materials with dynamic molecular functions
3.6.5. Emerging preference for minimally invasive surgery
4. Chapter four: biomaterial product market
4.1. Orthopedic biomaterial market
4.1.1. Market drivers
4.1.1.1. Product penetration
4.1.1.2. Increase in demand for orthopedic biomaterial products in spine surgery
4.1.1.3. Easy surgical procedures
4.1.2. Market inhibitors
4.1.2.1. Economic constraints
4.1.2.2. Increase in competition has led to lesser profit margin
4.1.3. Opportunities
4.1.3.1. Spinal treatment expected to be on the rise
4.1.4. Top player analysis of orthopedic biomaterial market
4.1.5. Orthopedic reconstructive
4.1.5.1. Market drivers
4.1.5.1.1. Availability of a wide range of products for specific application
4.1.5.1.2. New materials with improved properties are developed to create demand
4.1.5.2. Market inhibitors and opportunities
4.1.5.3. Top Players analysis in Orthopedic Reconstructive market
4.1.5.4. Artificial hip biomaterial market
4.1.5.4.1. Cemented prostheses biomaterial market
4.1.5.4.2. Uncemented prostheses biomaterial market
4.1.5.5. Artificial knee biomaterial market
4.1.5.5.1. Non-constraint implants
4.1.5.5.2. Semi-constraint implants
4.1.5.5.3. Constraint implants
4.1.6. Trauma biomaterial product market
4.1.6.1. Market Drivers
4.1.6.1.1. Sports and other accidents are fuelling the trauma market
4.1.6.1.2. Innovation is a growth factor in trauma market
4.1.6.1.3. Plate and screw systems are driving the growth
4.1.6.2. Top Players analysis of Trauma Orthopedic biomaterial market
4.1.7. Orthobiologics
4.1.7.1. Top player analysis of orthobiologics biomaterial market
4.1.7.2. DBM
4.1.7.3. Machined bone allografts
4.1.7.4. Non proprietary allografts
4.1.7.5. Synthetic bone substitute
4.1.7.6. Bone morphogenic protein (BMP)
4.1.7.7. Platelet concentrates
4.1.8. Sports medicine
4.1.8.1. Market Drivers
4.1.8.1.1. Varying characteristics of implants suit the needs of operative sports
4.1.8.1.2. Quick healing medicines boost growth
4.1.8.2. Top player analysis of sports medicine orthopedic biomaterial market
4.1.9. Bone cement
4.1.9.1. Market Drivers
4.1.9.1.1. Lesions can be eased using bone cements
4.1.9.1.2. Bone cements can be used with antibiotics
4.1.9.2. Inhibitors and opportunities
4.1.9.3. Top player analysis of bone cement orthopedic biomaterial market
4.1.10. Spinal
4.1.10.1. Drivers
4.1.10.1.1. Spinal treatment for younger patients on the rise
4.1.10.1.2. Motion preserving devices drives growth
4.1.10.2. Inhibitors
4.1.10.3. Opportunities
4.1.10.4. Top player analysis of spine orthopedic biomaterial market
4.1.10.5. Cervical
4.1.10.6. Lumbar
4.1.11. Dental
4.1.11.1. Drivers
4.1.11.1.1. Advantages of implants over dentures and bridges
4.1.11.1.2. Implants last lifelong
4.1.11.2. Inhibitors and opportunities
4.1.11.3. Top player analysis of dental orthopedic biomaterial market
4.1.11.4. Dental bone graft and substitute
4.1.11.5. Allograft
4.1.11.6. Xenograft
4.1.11.7. Synthetic dental bone graft and substitute market
4.1.11.8. Tissue regeneration
4.1.11.9. Dental membranes
4.2. Cardiovascular
4.2.1. drivers
4.2.1.1. Advancements in treatments
4.2.1.2. Rising number of obesity cases affecting the growth of the procedures that use these products
4.2.1.3. Increase in thrombosis and heart failure treatments drive growth
4.2.1.4. Vascular surgery market is growing with the uses of biomaterials
4.2.2. Inhibitors and opportunities
4.2.3. Top player analysis of cardiovascular biomaterials market
4.2.4. Cardiac pacemakers biomaterial market
4.2.4.1. Top player analysis of cardiac pacemaker cardiovascular biomaterial market
4.2.5. Implantable Cardioverter Defibrillator
4.2.5.1. Top player analysis of implantable cardioverter defibrillator cardiovascular biomaterial market
4.2.6. Cardiac Stent
4.2.6.1. Top player analysis of cardiac stents biomaterial market
4.2.7. Artificial heart valves
4.2.7.1. Top player analysis of artificial heart valve cardiovascular biomaterial market
4.2.8. Vascular Access devices
4.2.8.1. Market Drivers
4.2.8.1.1. Demand for advanced cardiac care in developing countries
4.2.8.1.2. Eliminates repeated needle sticks
4.2.8.2. Inhibitors and opportunities
4.2.8.3. Top player analysis of vascular access devices biomaterial market
4.2.9. Peripheral vascular grafts
4.3. Wound care products
4.3.1. drivers
4.3.1.1. Multiple advantages over conventional wound care products
4.3.1.2. Supports healing process of the skin
4.3.1.3. Advanced gel based products help accelerate the healing of wounds in special category of patients
4.3.1.4. Prevention of bacterial colonization on sutures
4.3.1.5. Reduction in the cost of hospitalization
4.3.1.6. Eliminates frequent change of dressings
4.3.1.7. Increase in Diabetes foot ulcer
4.3.2. Inhibitors
4.3.3. Opportunities
4.3.3.1. Increase in penetration of negative pressure wound therapy outside the U.S.
4.3.3.2. Introduction of more efficient and cost effective therapies
4.3.3.3. Usage of natural polymer biomaterials for stability in treatment
4.3.4. Top player analysis of wound care biomaterial market
4.3.5. Internal tissue sealant
4.3.5.1. Drivers
4.3.5.1.1. Technological advances
4.3.5.1.2. Wide range of applications and features
4.3.5.1.3. Faster healing
4.3.5.2. Top player analysis of internal tissue sealant wound care biomaterial market
4.3.5.3. Fibrin Sealants
4.3.5.4. Synthetic sealants
4.3.6. Surgical Hemostats
4.3.6.1. Market Drivers
4.3.6.1.1. New surgical hemostats provide improved control of bleeding
4.3.6.1.2. Reduces the need for frequent blood transfusions
4.3.6.2. Inhibitors and opportunities
4.3.6.3. Top player analysis of surgical hemostats market
4.3.6.4. Thrombin-based hemostats
4.3.6.5. Oxidized regenerated cellulose based topical hemostats
4.3.6.6. Gelatin-based hemostats
4.3.6.7. Combination hemostats
4.3.6.8. Collagen based hemostats
4.3.6.9. Autologous based hemostats
4.3.6.10. Polysaccharide based hemostats
4.3.7. Adhesion barriers
4.3.7.1. Drivers
4.3.7.1.1. Absorbable barriers are developed for surgeries
4.3.7.1.2. Reduces adhesion probability
4.3.7.2. Inhibitors and opportunities
4.3.7.3. Top player analysis of adhesion prevention wound care biomaterial market
4.3.7.4. Films
4.3.7.5. Gels
4.3.8. Skin substitutes
4.3.9. drivers
4.3.9.1. Increased incidences of gastro-intestinal diseases
4.3.9.2. FDA approval for shifting gastrointestinal drugs from prescription drugs to over-the-counter
4.3.10. Inhibitors
4.3.10.1. Lack of awareness of probiotic cultured materials
4.3.11. Opportunities
4.3.11.1. New developments coming up in gastrointestinal wound healing
4.3.12. Top player analysis of gastrointestinal biomaterial market
4.4. Urological market
4.4.1. drivers
4.4.1.1. Availability of biodegradable materials for treatment
4.4.1.2. Development of scaffolds for the treatment of several disorders
4.4.2. Inhibitors and Opportunities
4.4.3. Top player analysis of urological biomaterial market
4.4.4. Urological stents
4.4.4.1. Market Drivers
4.4.4.1.1. Stents are used in short duration treatment
4.4.4.1.2. Broad indications and growing population boost the market
4.4.4.2. Inhibitors and Opportunities
4.4.5. Urological catheters
4.4.5.1. Drivers
4.4.5.1.1. New approach in catheter design has set performance standards to increase demand
4.4.5.1.2. Increased applicability of catheters boost the market
4.4.5.2. Inhibitors
4.4.5.3. Opportunities
4.4.5.3.1. Use of biomaterials in catheters eliminates certain disadvantages
4.4.5.3.2. Biocompatibility of chemicals can be improved in catheters
4.4.5.4. Dialysis catheter
4.4.5.4.1. Top player analysis of dialysis catheter market
4.4.5.5. Hemodialysis catheter
4.4.5.6. Peritonial catheter
4.4.5.7. Urinary catheter
4.4.5.8. Indwelling catheter
4.4.5.9. External catheter
4.4.5.10. Intermittent catheter
4.5. Plastic surgery
4.5.1. Market Drivers
4.5.1.1. More surgeons are moving towards plastic surgery market from reconstructive procedures
4.5.1.2. Cultural factors boost the market growth
4.5.1.3. Baby boomers to boost the market growth
4.5.2. Market Inhibitors
4.5.2.1. Difficulties in treating craniofacial trauma
4.5.3. Opportunities
4.5.3.1. Market has not tapped men for facial surgeries
4.5.3.2. Development of advanced procedures for quick patient recovery
4.5.4. Top player analysis of plastic surgery biomaterial market
4.5.5. Breast Implants
4.5.5.1. Drivers
4.5.5.1.1. More refined procedures are available
4.5.5.1.2. Choices available for breast implants are wider
4.5.5.2. Inhibitors
4.5.5.3. Opportunities
4.5.5.3.1. Reduction in complications will be an opportunity
4.5.5.3.2. Safety issues need to be addressed
4.5.5.4. Top player analysis of breast implants biomaterial market
4.5.5.5. Saline filled implants
4.5.5.6. Silicone filled implants
4.5.6. Injectable fillers
4.5.6.1. Drivers
4.5.6.1.1. Anti-aging has driven the market growth
4.5.6.1.2. Permanent results can be achieved using fillers
4.5.6.2. Inhibitors
4.5.6.2.1. Allergy reaction and re-absorption is a concern in injectable fillers
4.5.6.3. Opportunities
4.5.6.3.1. FDA approval not needed for fat fillers
4.5.6.4.Top player analysis of injectable fillers biomaterial market
4.5.7. Facial Implants
4.5.7.1. Drivers
4.5.7.1.1. Iraq war increased the demand for facial implants
4.5.7.1.2. Faster recovery and surgery times
4.5.7.2. Inhibitors
4.5.7.3. Opportunities
4.5.7.4. Top player analysis of facial implants biomaterial market
4.6. Other biomaterials
5. Chapter five: Biomaterial market
5.1. Ceramics
5.1.1. Drivers
5.1.1.1. Low stress shielding
5.1.1.2. No disease transmission
5.1.1.3. Material supply is unlimited
5.1.2. Inhibitors and opportunities
5.1.3. Top player analysis of ceramics market
5.1.4. Bioinert ceramics
5.1.4.1. Drivers
5.1.4.1.1. Can be used for high strength applications
5.1.4.1.2. They show high chemical stability
5.1.4.2. Inhibitors
5.1.4.3. Opportunities
5.1.4.3.1. Alumina
5.1.4.3.2. Drivers
5.1.4.3.3. Inhibitors
5.1.4.3.4. Opportunities
5.1.4.4. Zirconia ceramic
5.1.4.4.1. Drivers
5.1.4.4.2. Inhibitors
5.1.4.4.3. Opportunities
5.1.4.5. Other bioinert ceramics market
5.1.5. Bioactive ceramics
5.1.5.1. Drivers
5.1.5.1.1. They help in bone formation
5.1.5.1.2. They bond with living bone tissue
5.1.5.1.3. Inhibitors and Opportunities
5.1.5.2. Bioglass
5.1.5.2.1. Drivers
5.1.5.2.2. Inhibitors
5.1.5.2.3. Opportunities
5.1.5.3. Other bioactive ceramics market
5.1.6. Biodegradable ceramics
5.1.6.1. Drivers
5.1.6.1.1. They are the least toxic of ceramics
5.1.6.1.2. The degradable rate can be tailored
5.1.6.2. Inhibitors and opportunities
5.1.6.3. Hydroxyapetite
5.1.6.3.1. Drivers
5.1.6.3.2. Inhibitors
5.1.6.3.3. Opportunity
5.1.6.4.Others biodegradable biomaterial market
5.2. Metals
5.2.1. Drivers
5.2.1.1. Balancing act of metallic biomaterials
5.2.1.2. Improved properties of metallic biomaterials
5.2.2. Inhibitors
5.2.3. Opportunities
5.2.3.1. Improvement in corrosion resistance
5.2.3.2. Introduction of new alloys
5.2.4. Top player analysis of metallic biomaterial market
5.2.5. Pure form metals
5.2.5.1. Titanium
5.2.5.2. Gold
5.2.5.3. Silver
5.2.5.4. Platinum
5.2.6. Alloys
5.2.6.1. Drivers
5.2.6.1.1. Availability of ore for biomaterials manufacture
5.2.6.1.2. Can be sterilized easily
5.2.6.2. Inhibitors and opportunities
5.2.6.3. Top player analysis of alloy biomaterial market
5.2.6.4. High Carbon Cobalt Chromium alloy
5.3. Polymers
5.3.1. Drivers
5.3.1.1. Biodegradable naturally
5.3.1.2. Compatibility in imaging
5.3.2. Inhibitors and opportunities
5.3.3. Top player analysis of polymer biomaterial market
5.3.4. Natural polymers
5.3.4.1. Drivers
5.3.4.1.1. They are safe for use
5.3.4.1.2. They work at a molecular level
5.3.4.2. Inhibitors and opportunities
5.3.4.3. Collagen Market
5.3.4.4. Chitosan
5.3.4.5. Alginate
5.3.4.6. Others natural polymers
5.3.5. Synthetic polymers
5.3.5.1. PLA/PGA
5.3.5.2. PTFE (polytetrafluoroethylene)
5.3.5.3. Other synthetic polymers
6. Chapter Six: Application market
6.1. General surgery
6.1.1. Drivers
6.1.1.1. Suturing has become easier with the synthetic biomaterials
6.1.1.2. Stringent requirements of surgeons are met by biomaterials
6.1.1.3. Biomaterials are used as adhesion prevention materials
6.1.2. Inhibitors
6.1.3. Opportunities
6.1.3.1. The development of a permanent solution for adhesion prevention
6.1.3.2. Properties of biomaterials can be improved to increase usage
6.2. Surgical Appliances and supplies
6.2.1. Drivers
6.2.1.1. Advanced materials for surgical appliances drives growth
6.2.1.2. Surgical advances in orthopedic and prosthetic applications
6.2.1.3. Increased healthcare spending by developed countries
6.2.1.4. Tissue engineering doesn’t have any side effects
6.2.1.5. Biomaterials are used to accelerate natural phenomena
6.2.2. Market Inhibitors
6.2.2.1. Reduced availability of outside capital
6.2.2.2. Tissue engineering may require reoperation
6.2.2.3. The process of approving is slow
6.2.3. Opportunities
6.2.3.1. Demographic factors will provide growth
6.2.3.2. Increase in export opportunities
6.2.3.3. Development of artificial organs in future
6.2.3.4. Treatment of sleep disorder is under investigation
6.3. Drug delivery applications
6.3.1. Drivers
6.3.1.1. Enabling properties of biomaterials drive growth
6.3.1.2. Most of the biomaterials are bio-absorbable
6.3.1.3. Quick and effective methods have been developed
6.3.2. Inhibitors
6.3.3. Opportunities
6.4. Dental products
6.4.1. Drivers
6.4.1.1. Biomaterials have wider dental applications
6.4.1.2. Risk of dental disease is set to increase
6.4.1.3. Improvement in polymers used for dental applications
6.4.2. Inhibitors
6.4.3. Opportunities
6.5. Surgical and Medical Instruments
6.5.1. Drivers
6.5.1.1. Breakthrough in innovations of surgical instruments drive growth
6.5.1.2. Availability of cheap surgical instruments
6.5.2. Inhibitors
6.5.3. Opportunities
6.6. Electro medical equipment application
6.6.1. Drivers
6.6.1.1. There is a substantial increase in the number of patients
6.6.1.2. Demand for efficient procedures and economies of scale
6.6.2. Inhibitors
6.6.2.1. Polymers used in the equipment are prone to release toxic agents
6.6.2.2. There is a possibility of electrical leakage
6.6.3. Opportunities
6.7. Other applications
7. Chapter Seven: Geographic Analysis of biomaterial market
8. Chapter eight: Company profiles
8.1. 3DM, Inc.
8.2. AdvanSource Biomaterials Corporation
8.3. Allergan Inc.
8.4. AlloSource
8.5. Alphatec Spine, Inc.
8.6. Amedica Corporation
8.7. Angiotech Pharmaceuticals, Inc.
8.8. ApaTech Ltd.
8.9. Artimplant AB
8.10. Biocoral, Inc.
8.11. BioInteractions Ltd.
8.12. Bioretec Ltd.
8.13. Bio Syntech Canada Inc.
8.14. Boston Scientific Corporation
8.15. Collagen Matrix, Inc.
8.16. Corin Group PLC
8.17. Covalon technologies
8.18. CryoLife Inc.
8.19. Davol, Inc.
8.20. Depuy Orthopaedics Inc.
8.21. ETEX Corporation
8.22. Forticell Bioscience, Inc.
8.23. Genzyme Biosurgery
8.24. Haemacure Corporation
8.25. Inion Oy
8.26. Integra Lifesciences Holdings Corp.
8.27. International Biocomposites Ltd.
8.28. Invibio Ltd.
8.29. ISTO Technologies, Inc.
8.30. Kensey Nash Corporation
8.31. Medtronic, Inc.
8.32. Mentor Corporation
8.33. MIV Therapeutics Inc.
8.34. Olympus Terumo Biomaterials Ltd.
8.35. Organogenesis, Inc.
8.36. Orthovita
8.37. Osteotech, Inc.
8.38. Pioneer Surgical Technology
8.39. Polymer Technology Group
8.40. Protein Polymer Technologies Inc.
8.41. RTI Biologics, Inc.
8.42. Smith & Nephew plc
8.43. Stryker Corporation
8.44. Synthes, Inc.
8.45. TEI Biosciences
8.46. TORNIER Inc.
8.47. Vygon S.A
8.48. W.L. Gore & Associates Inc.
8.49. Wright Medical Group, Inc.
8.50. Zimmer Holding, Inc.
9. Chapter nine: Patent analysis
Appendix
1. U.S. biomaterial product patents
2. Europe biomaterial product patents
3. Asia biomaterial product patents
4. U.S. biomaterial patents
5. Europe biomaterial patent
6. Asia biomaterial patents

Biomaterials Find Wide Usage in the Medical Devices Industry

The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications.

The biomaterials market has grown at a CAGR of more than 8% in the past two years to reach a current market size of $28 billion. In the next five years, the market is expected to grow at a CAGR of 15%, riding high on new product developments. This highlights the many opportunities that this market offers in terms of revenues and market growth.

The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market.

Improved patient benefits form the most important factor stimulating market growth for biomaterials. The other market drivers are increase in aging population, rising awareness, shorter product approval time, and larger application area. However, the lack of tissue availability and proper reimbursement facilities are restraining the growth of the biomaterials market. Improvement in fabrication technology and new product development at competitive prices will be the key to future market growth.

The biomaterials market is still in a growing phase, with about 100,000 heart valves, 200,000 pacemakers and 1 million orthopedic devices implanted worldwide every year. The U.S. and Europe hold a major share of the global biomaterials market; while emerging economies such as China, India, Japan, Brazil, Russia, and Romania represent a high growth rate.

Global biomaterials market by products, 2009

Source: MarketsandMarkets

Orthopedic biomaterials are expected to be the dominant segment in global biomaterials market with 38% market share, closely followed by cardiovascular biomaterials with 37%. The market growth for these two segments is driven mainly by the increase in ageing population in developed and developing countries. More than 20% of the global population in 2050 is expected to be over 60 years of age. The markets for wound care, plastic surgery, and urology applications are also expected to grow at a high rate. Regenerative treatments and biodegradable products hold the key for future investments.

The key players in the global biomaterials market are Boston Scientific, DePuy, Invibio, Medtronic Inc., Synthes Inc., and Zimmer. Agreements and collaborations, new product launches, and geographic expansion are the most popular strategies that the companies employ to combat competition. Our patent analysis indicates that the U.S. has the highest percentage (45%) of patents filed, followed by Europe with 36%. Also, in 2008, the number of patents registered in Asia increased from 8% to 16%.

Source : http://www.biotech-market-reports.com/

You might also enjoy:

• Mold Allergy Symptoms and Treatments
• How can I remove household mold from moist walls ?
• Don’t you hate when your guilty pleasure doesn’t cut it?
• Celiac disease affects 1 in 100. But Global diagnosis is related to a country’s wealth. See the results of gluten free demand in GFP Matrix analysis
• Food Allergy In Dogs: Their Next Bite Could Be Worse Than Their Bark!

Similar Allergy Articles

• What are Allergy Shots For?
• Understanding Mold allergies
• Best Seasonal Allergy Treatments that you can Explore
• Allergies Symptoms and Natural Foods That Fight Allergies
• Mold Allergy Symptoms and Treatments